Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::

黃德光 (De-Kuang Huang)

[Profile]

  • Education
    • MD, School of Medicine; National Defense Medical Center, National Defense University, Taipei, Taiwan,
    • PhD, Institution of Public Health & Department of Public Health; National Yang Ming University, Taipei, Taiwan ,
  • Career and Experience
    Current Positions:
    Experiences:
    • - , Associate Director, Patient Care Team, Center for Quality Management, Taichung Veterans General Hospital: , Taichung, Taiwan
    • - , Attending Physician, Uveitis Service & Retina Service, Department of Ophthalmology, Taichung Veterans General Hospital, Taichung , Taiwan
    • - , Attending Physician, Taoyuan Branch, Taipei Veterans General Hospital , Taiwan
    • - , Resident, Chief Resident, Clinical Fellow, Ophthalmology , Taipei Veterans General Hospital, Taipei, Taiwan
    • - , Adjunct Attending Physician, Taipei Outpatient Center, National Health Insurance Administration–, Taipei , Taiwan
  • Medical Expertise
    1. Uveitis and Retina
  • License
    Practicing License, Taiwan 3.Board Certification of the Ophthalmology Society, Taiwan 4.Certification and Qualification of Teacher in Post-Graduate General Medicine, Taiwan Association of Medical Education, 5.Certification of Completing Advanced Cardiac Life Support Training Course, Society of Emergency & Critical Care Medici

[Publications]

  1. Epidemiology of uveitis among the Chinese population in Taiwan: a Population-Based Study. Ophthalmology 2012 Nov; 119(11): 2371-6
  2. Step-wise Diagnostic Approach for Patients with Uveitis - Experts Consensus in Taiwan. the Journal of Microbiology, Immunology and Infection. 2022 Aug;55(4):573-580
  3. Diagnosis, Treatment, and Prevention of Noninfectious Acute Anterior Uveitis with or without Human Leukocyte Antigen B27 in Adults - Expert Consensus in Taiwan. Ocul Immunol Inflamm. 2024 Feb;32(2):226-233
  4. Elevation of serum oxidative stress in patients with retina vein occlusions. Acta Ophthalmology 2019 Mar; 97(2): e290-e295
  5. Three-year outcomes of patients with neovascular age-related macular degeneration treated with aflibercept under the National Health Insurance program in Taiwan. Journal of Ophthalmology 2020 Feb.; 2020: 4538135.
  6. Genome-wide association study and identification of systemic comorbidities in development of age-related macular degeneration in a hospital-based cohort of Han Chinese. Front Genet. 2023; 14: 1064659.
回到最上